Despite their benefits in the treatment of cardiovascular disease, ß-blockers are seldom used to treat asthmatics. We assessed the safety and tolerability of acute dosing with esmolol and propranolol in patients with asthma.
|Number of pages||5|
|Journal||Heart (British Cardiac Society)|
|Early online date||7 Nov 2013|
|Publication status||Published - Feb 2014|
FingerprintDive into the research topics of 'Effects of intravenous and oral β-blockade in persistent asthmatics controlled on inhaled corticosteroids'. Together they form a unique fingerprint.
- Molecular and Clinical Medicine - Clinical Professor (Teaching and Research) of Allergy and Respiratory Medicine